Literature DB >> 31063379

Antibiotic Adjuvants: Make Antibiotics Great Again!

Hana Douafer1, Véronique Andrieu2, Otto Phanstiel3, Jean Michel Brunel1.   

Abstract

Multiple approaches have been developed to combat bacterial resistance. However, the combination of antibiotic resistance mechanisms by bacteria and the limited number of effective antibiotics available decreases the effective interventions for the treatment of current bacterial infections. This review covers the many ways that bacteria resist antibiotics including antibiotic target modification, the use of efflux pumps, and antibiotic inactivation. As a pertinent example, the use of beta lactamase inhibitors in combination with β-lactam containing antibiotics is discussed in detail. The solution to emerging antibiotic resistance may involve combination therapies of existing antibiotics and potentiating adjuvants, which re-empower the antibiotic agent to become efficacious against the resistant strain of interest. We report herein that a reasoned adjuvant design permits one to perform polypharmacy on bacteria by not only providing greater internal access to the codosed antibiotics but also by de-energizing the efflux pumps used by the bacteria to escape antibiotic action.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31063379     DOI: 10.1021/acs.jmedchem.8b01781

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  30 in total

1.  RNase I Modulates Escherichia coli Motility, Metabolism, and Resistance.

Authors:  Yashasvika Duggal; Benjamin M Fontaine; Deanna M Dailey; Gang Ning; Emily E Weinert
Journal:  ACS Chem Biol       Date:  2020-07-02       Impact factor: 5.100

2.  Klebsiella pneumoniae Expressing VIM-1 Metallo-β-Lactamase Is Resensitized to Cefotaxime via Thiol-Mediated Zinc Chelation.

Authors:  Harpa Karadottir; Maarten Coorens; Zhihai Liu; Yang Wang; Birgitta Agerberth; Christian G Giske; Peter Bergman
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

3.  A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.

Authors:  Meirong Song; Yuan Liu; Xiaoyong Huang; Shuangyang Ding; Yang Wang; Jianzhong Shen; Kui Zhu
Journal:  Nat Microbiol       Date:  2020-05-18       Impact factor: 17.745

Review 4.  Constructing and deconstructing the bacterial cell wall.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Protein Sci       Date:  2019-11-20       Impact factor: 6.725

5.  The Polyaminoisoprenyl Potentiator NV716 Revives Old Disused Antibiotics against Intracellular Forms of Infection by Pseudomonas aeruginosa.

Authors:  Gang Wang; Jean-Michel Brunel; Jean-Michel Bolla; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

6.  Fluorescence Assessment of the AmpR-Signaling Network of Pseudomonas aeruginosa to Exposure to β-Lactam Antibiotics.

Authors:  David A Dik; Choon Kim; Chinedu S Madukoma; Jed F Fisher; Joshua D Shrout; Shahriar Mobashery
Journal:  ACS Chem Biol       Date:  2020-02-10       Impact factor: 5.100

Review 7.  Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.

Authors:  Ronit Vogt Sionov; Doron Steinberg
Journal:  Microorganisms       Date:  2022-06-16

8.  Antivirulence Agent as an Adjuvant of β-Lactam Antibiotics in Treating Staphylococcal Infections.

Authors:  Peng Gao; Yuanxin Wei; Sherlock Shing Chiu Tai; Pradeep Halebeedu Prakash; Ho Ting Venice Iu; Yongli Li; Hin Cheung Bill Yam; Jonathan Hon Kwan Chen; Pak Leung Ho; Julian Davies; Richard Yi Tsun Kao
Journal:  Antibiotics (Basel)       Date:  2022-06-17

Review 9.  Antimicrobial Peptides and Cationic Nanoparticles: A Broad-Spectrum Weapon to Fight Multi-Drug Resistance Not Only in Bacteria.

Authors:  Giulia E Valenti; Silvana Alfei; Debora Caviglia; Cinzia Domenicotti; Barbara Marengo
Journal:  Int J Mol Sci       Date:  2022-05-29       Impact factor: 6.208

10.  Isolation and structural characterization of a Zn2+-bound single-domain antibody against NorC, a putative multidrug efflux transporter in bacteria.

Authors:  Sushant Kumar; Ithayaraja Mahendran; Arunabh Athreya; Rakesh Ranjan; Aravind Penmatsa
Journal:  J Biol Chem       Date:  2019-11-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.